Peptide payment processing 101 for new operators

You launched a peptide brand, the orders are coming in, and you just learned the hard way that Stripe will not let you keep the money. Welcome to the part of the business nobody told you about. Payment processing for peptides is its own discipline, and the operators who treat it as an afterthought spend their first year getting frozen, scrambling, and getting frozen again. The ones who learn the basics up front pick the right account once and get on with selling.

This is the basics, written for someone who has never run a high-risk merchant account. No jargon without a definition, no upsell. By the end you will know who will actually approve you, what the numbers mean, and the three mistakes that close first-year peptide accounts.

First, the platforms that will never work

Stripe, Square, PayPal, Braintree, and Shopify Payments all decline peptides per their published restricted-business lists. This is not a gray area you can finesse with careful wording. The category is excluded by policy. An account may process for a few weeks before review catches the catalog, which fools new operators into thinking they slipped through — but the closure is coming, and every closure makes the next account harder to open.

So the first rule is simply: do not apply to them. Not under a supplement name, not under a different entity. The Stripe-for-peptides comparison shows exactly how that story ends. Save your application attempts for processors that will say yes.

Who actually approves peptides

Peptides live on specialist high-risk acquirers, reached through an independent sales organization (an ISO). The names you will hear: EasyPayDirect, Durango, Corepay, Soar, and PayKings. They pair an acquiring bank that accepts peptides with a payment gateway — usually Authorize.net or NMI — that handles the technical card processing.

The mental model: the merchant account is the bank relationship that holds your funds and carries your risk; the payment gateway is the software that moves the card data. You need both, and the ISO sets them up together. For a first peptide brand, start here. Our peptide-operator overview points to the right ISO based on whether you are brand new or rebuilding after a closure.

The three terms that decide your first year

Before you sign anything, understand these. They matter more than the brand name on the contract.

Effective rate

Your effective rate is total fees divided by total volume — the real all-in percentage you pay, not the teaser number on the quote. A "from 3.5%" pitch can land at 4.3% once you add per-transaction fees, gateway fees, and assessments. Always ask for the effective rate on a sample month. For peptides, expect 3.9-4.5% effective in year one, dropping toward 3.5-4.0% after 12-18 months of clean processing.

Rolling reserve

A rolling reserve is a percentage of each day's sales the acquirer holds back and releases on a delay, as a buffer against future chargebacks and refunds. For new peptide accounts, 10-15% held 180 days is standard. On a $50k month at 15%, that is $7,500 of your own money held for six months — every month, until the oldest reserve ages off. It is not a fee; you eventually get it back. But it is cash you cannot spend now, so plan for it.

Chargeback ratio

Your chargeback ratio is disputed transactions divided by total transactions. This single number decides whether your account survives. Visa's excessive threshold is 0.9%; Mastercard's is 1.0%. Cross those and you enter a monitoring program with fines. Stay well under, and your rate and reserve improve over time.

What the numbers look like together

Interchange — the wholesale cost set by the card networks — runs about 1.65-2.60% plus roughly $0.10 per card-not-present credit transaction, and sits underneath your effective rate. A fair processor does not mark interchange up; the markup is their margin on top. Knowing the baseline keeps you from overpaying.

How chargebacks actually work, briefly

Since the chargeback ratio is the number that decides your account's survival, it helps to know what a chargeback is. When a customer disputes a charge with their bank instead of asking you for a refund, the bank pulls the money back and assigns a reason code describing why — item not received, not as described, unauthorized, and so on. You can fight it by submitting evidence, called representment: tracking and delivery confirmation, the order record, customer communications, your refund policy.

Two things every new operator should internalize. First, a refund is cheap and a chargeback is expensive — beyond losing the sale, each dispute costs a fee and counts against your ratio whether you win it or not. So make refunds easy; a customer who can get a refund in two clicks does not call their bank. Second, win your winnable disputes. Many peptide chargebacks are item-not-received claims you can defeat with a tracking number, but only if you actually submit the evidence before the deadline. Operators who ignore representment watch a beatable ratio climb toward the 0.9% line for no reason.

The three mistakes that close first-year accounts

• Misrepresenting your vertical. Applying as a supplement or cosmetics company to get a cheaper rate gets caught in the website review, and now you have a misrepresentation flag instead of a peptide account. Apply as what you are.
• Ignoring compliance on your site. Acquirers read your product pages. Missing research-use labeling, no age gate, no visible refund policy, no COAs — each one raises your reserve or kills the application. Fix the site before you apply.
• Letting chargebacks pile up at launch. Aggressive affiliate funnels and unclear billing descriptors spike disputes early, and your first 90 days set your reserve and rate for the next year. A clear billing descriptor that customers recognize on their statement is the cheapest chargeback prevention there is.

What to have ready before you apply

The single biggest factor in how fast you get approved, and at what reserve, is how complete your application is. New operators stall in review because they apply with half the package. Gather these before you submit:

• A compliant, finished website. Live product pages with research-use labeling, an age gate, a visible refund and shipping policy, and a contact page. The acquirer reviews the real site, not a coming-soon page.
• COAs per SKU. Certificates of analysis for your products, accessible from the product pages. Their presence signals a legitimate operation and lowers your perceived risk.
• Processing history, if you have it. Three months of statements from any prior processor. If you are brand new, a realistic monthly volume projection instead.
• Business documentation. EIN, business bank account in the business name, and a matching legal entity. Mismatches between your entity name, bank, and website slow everything down.

A clean package can mean the difference between a 10-15% reserve and a 20% one, and between approval in a week versus three weeks of back-and-forth. Treat the application as the first impression it is.

A word on alternative payment methods

Cards are the core of your revenue, but smart peptide operators keep one or two backups wired up for the gap between accounts or for high-value orders. ACH and wire transfer work for larger purchases where the customer is willing. Crypto covers some volume but typically converts 70-85% worse than cards as a sole method, so treat it as a backup, never a primary. The point is resilience: if your card processing ever pauses, a backup rail keeps the highest-value orders flowing while you sort it out. Do not build the whole business on backups, but do not launch with zero either.

When you have one brand vs. several

Almost every new operator has one peptide brand, and for one brand the answer is simple: a specialist ISO on Authorize.net or NMI, full stop. You do not need anything fancier, and anyone selling you an orchestration layer for a single brand is selling you overhead.

The picture changes only if you grow into multiple brands. At 3+ peptide brands, running a separate merchant account per brand becomes its own job — duplicate reserves, reconciliations, and freeze risks. That is when a parent-account model is worth evaluating, and it is the one case where multiflow fits: an orchestration layer on top of an acquirer that makes several brands behave like one operation. It does not process or settle funds itself. For now, as a new operator, file that away and focus on getting one clean account. The how-it-works page is there when you scale.

Peptide processing is not complicated once you know the vocabulary: skip the platforms that ban you, go to a specialist ISO, read the effective rate and reserve before signing, and keep your chargeback ratio under 0.9%. Do those four things and your first year is boring, which in payments is exactly what you want. If you are brand new and want a straight read on the right first account — even if that answer is a specialist ISO and not us — talk to an underwriter. Twelve questions, no hard pull, an honest answer in 48 hours.